OBESITY OR OVERWEIGHT
Clinical trials for OBESITY OR OVERWEIGHT explained in plain language.
Never miss a new study
Get alerted when new OBESITY OR OVERWEIGHT trials appear
Sign up with your email to follow new studies for OBESITY OR OVERWEIGHT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New obesity injection tested for safety with common heart and cholesterol drugs
Disease control Recruiting nowThis early-stage study is testing an experimental injection called GZR18 in people who are overweight or obese. The main goals are to see how the injection affects how quickly the stomach empties and whether it changes how the body processes three common medications (digoxin, ros…
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE1 • Sponsor: Gan & Lee Pharmaceuticals. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New weekly shot aims to help millions shed pounds and control diabetes
Disease control Recruiting nowThis study is testing a new weekly injection called RO7795068 to see if it helps people with obesity or overweight and type 2 diabetes lose weight and better control their blood sugar. About 1,600 participants will receive either the active drug or a placebo (dummy injection) for…
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New combo therapy aims to tame bowel disease and shed pounds
Disease control Recruiting nowThis study is testing whether adding a weight-loss drug (tirzepatide) to a standard ulcerative colitis drug (mirikizumab) works better than the colitis drug alone. It's for adults who have active ulcerative colitis and are also overweight or have obesity. The main goals are to se…
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Major trial tests new weekly shot for significant weight loss
Disease control Recruiting nowThis study is testing a new weekly injection, called RO7795068, to see if it helps people with obesity or overweight lose weight and keep it off. It will involve about 2000 adults who do not have type 2 diabetes. The main goal is to see how much body weight participants lose afte…
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Double-Duty drugs: new trial targets Crohn's flares and weight
Disease control Recruiting nowThis study is testing whether adding a weight-loss drug (tirzepatide) to a Crohn's disease drug (mirikizumab) works better than the Crohn's drug alone. It's for adults who have active Crohn's disease and are also overweight or have obesity. The main goal is to see if the combinat…
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC